Page last updated: 2024-08-23

cromolyn sodium and ipi-145

cromolyn sodium has been researched along with ipi-145 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beck, G; Bouchaud, G; Boumendjel, A; Boyère, C; Dumontet, C; Esmenjaud, J; Gardebien, F; Haudecoeur, R; Magnan, A; Matera, EL; Mathé, D; Mattei, E; Monneret, G; Nurisso, A; Pérès, B; Peuchmaur, M; Tourette, A	1

Other Studies

1 other study(ies) available for cromolyn sodium and ipi-145

Article	Year
Piperidinyl-embeded chalcones possessing anti PI3Kδ inhibitory properties exhibit anti-atopic properties in preclinical models. European journal of medicinal chemistry, 2018, Oct-05, Volume: 158 Topics: Animals; Asthma; Basophils; Cell Degranulation; Chalcones; Dermatitis, Atopic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Mice; Models, Molecular; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors	2018

Article

Year

Piperidinyl-embeded chalcones possessing anti PI3Kδ inhibitory properties exhibit anti-atopic properties in preclinical models.

European journal of medicinal chemistry, 2018, Oct-05, Volume: 158

Topics: Animals; Asthma; Basophils; Cell Degranulation; Chalcones; Dermatitis, Atopic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Mice; Models, Molecular; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors

2018